Armata Pharmaceuticals, Inc. (ARMP)

[timberwolf7]

agree on the low share count and even minor activity having a big impact on the price. Its already happening, chart shows it...

And further, if it wasn't for the promise and potential impact on society, I wouldn't even be wasting my time following this one.

BUT, they are like many a baby bio getting started also:

-in debt already
-limited cash on hand
-facing a big fiscal load to fund the trials
-high probability of secondaries to pay for the bills associated with the trials.
-and time to complete the trials

that said, based on their usage in the 'expanded access' program, they show a high degree of promise in terms of achieving what they seek to do. But and I have said it before, I wouldn't mind paying a lot less per share to stimulate buying and holding. Hell, at $4/sh, they are a price I wouldn't pay even after a successful phase 1... not with 3-4 years of potentially more holding to go thru..

that said, I have a baby miner about to go into production IF they get their permits (and the odds favor it happening).. that I am paying 10 cents/sh for (with the expectation that on permitting, they head for a $)

I have another baby bio halfway thru their ph 3, results from the PH 2 look good.. But what they are attempting to bring to market has a limited market, as such, there isn't a lot of interest in the company, so they have recently dropped to 25 cents/sh. I am looking at getting some of them at this price level, looking for a $ as approval approaches (1 1/2 years to go)

and have another one that I bought into at 30 cents/sh, that has run up to $1.6/sh and is working on getting their NDA submitted to the FDA for approval. And this one has a demand for their product, but could be up to a year before the FDA decision day takes place..

so to close, I don't mind buying and holding, but I don't like paying too much for something this far out.. But will continue to monitor cause one day, I will buy some if the PH 1/2 trial is completed successfully..